Teladoc Health (TDOC) Common Equity (2014 - 2026)

Teladoc Health has disclosed Common Equity across 13 years of filings, most recently posting $1.3 billion for Q2 2026.

• In Q2 2026, Common Equity fell 7.88% year-over-year to $1.3 billion; the TTM figure through Jun 2026 stood at $1.3 billion (down 7.88% YoY), while the FY2025 annual figure was $1.4 billion, down 7.07% from the prior year.
• Common Equity came in at $1.3 billion for Q2 2026 at Teladoc Health, down from $1.3 billion in the prior quarter.
• In the past five years, Common Equity ranged from a high of $9.1 billion in Q1 2022 to a low of $1.3 billion in Q2 2026.
• Average Common Equity over 5 years is $2.7 billion, with a median of $1.9 billion recorded in 2024.
• Year-over-year, Common Equity plunged 85.62% in 2022 and advanced 0.79% in 2023.
• Over 5 years, Common Equity stood at $2.3 billion in 2022, then increased by 0.79% to $2.3 billion in 2023, then slumped by 35.9% to $1.5 billion in 2024, then declined by 7.07% to $1.4 billion in 2025, then retreated by 5.46% to $1.3 billion in 2026.
• Per Business Quant data, the three most recent Common Equity figures were $1.3 billion in Q2 2026, $1.3 billion in Q1 2026, and $1.4 billion in Q4 2025.